(HealthDay News) — For U.S. adults with gastroesophageal reflux disease (GERD), the risk of myocardial infarction (MI) is slightly elevated among those using proton pump inhibitors, according to a review published online in PLOS ONE.
John Cooke, M.D., Ph.D., chair of cardiovascular sciences at the Houston Methodist Research Institute, and colleagues examined over 16 million clinical documents on 2.9 million individuals. The authors sought to assess the association between PPI usage and cardiovascular risk in the general population.
Overall, proton pump inhibitor users were found to be 16% more likely to suffer a MI than patients with chronic GERD who were not taking the drugs. H2-blockers were not linked to any increase in MI risk, the study authors noted
Continue Reading
Cooke told HealthDay that recent lab research suggests that proton pump inhibitors can interfere with normal blood vessel function — a potential mechanism by which the drugs could affect MI risk.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.